10-K: Naploy Corp. 10-K: Development Stage Company Faces Financial Hurdles

Naploy Corp. files its annual 10-K report, detailing its status as a development stage company with no significant revenue, a substantial accumulated deficit, and a going concern warning from its auditors.

Summary

• Naploy Corp. is a development stage company incorporated in Wyoming on April 6, 2023, focused on launching a health news blog and app.
• The company has incurred losses since inception and has no employees other than its two officers/directors.
• The company's primary product is the Naploy App, featuring a news blog, a Symptom Diagnostic tool powered by AI, and a Clinic Search feature.
• Revenue for the year ended July 31, 2026, was $18,097, an increase of 127.6% from $7,950 in the prior year, attributed to the start of sales in October 2024.
• Total operating expenses increased by 73.6% to $49,773 in fiscal year 2026, primarily due to higher general and administrative expenses.
• The company reported a net loss of $31,676 for the year ended July 31, 2026, compared to a net loss of $20,714 for the prior year.
• As of July 31, 2026, the company had total assets of $57,853, current liabilities of $100,657, and a stockholders' deficit of $42,804.
• The auditors have issued a going concern opinion, citing substantial doubt about the company's ability to continue as an ongoing business for the next twelve months.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a very negative score due to the company's development stage, lack of revenue, significant accumulated deficit, and the auditor's going concern warning, indicating substantial doubt about its ability to continue as a going concern.

Positives

• Revenue increased by 127.6% to $18,097 for the fiscal year ended July 31, 2026, compared to the prior year.
• The Naploy App has been launched on Android and iOS platforms.
• The company has a business plan and is actively developing its app features, including AI-powered symptom diagnosis and clinic search.
• The company has secured $1,375 in proceeds from the sale of common stock in the year ended July 31, 2025.
• The company has a plan to expand its services to other African countries after success in Nigeria.

Negatives

• The company has incurred losses since inception and has no sufficient revenue.
• The company has a substantial accumulated deficit of $79,071 as of July 31, 2026.
• The company has a stockholders' deficit of $42,804 as of July 31, 2026.
• The company has material weaknesses in its internal control over financial reporting, including lack of segregation of duties and an audit committee.
• The company's auditors have issued a going concern opinion, indicating substantial doubt about its ability to continue as an ongoing business.
• The company has only 10 active users for its Naploy App as of the reporting date.
• The company has no clients yet for its clinic search services.
• The company has no employees other than its two officers and directors.

Risks

• The company has limited operating history and has not yet realized sufficient revenues, leading to a going concern opinion from auditors.
• The company expects to incur operating losses in future periods due to significant start-up expenses.
• There is no assurance that the company will generate revenue or achieve positive cash flow.
• Failure to find enough customers could lead to the rapid depletion of proceeds from any offering, requiring alternative financing.
• The company operates in a highly competitive health app market with many established players.
• The company relies on open channels and trusted platforms for content, with no content licensing agreements.
• The company has no employees other than its officers and directors, and plans to hire freelance managers only after securing its first client.
• The company has no patents or trademarks.

Future Outlook

The company plans to continue developing and expanding the Naploy App's functionality, including improving AI technology, adding map view, reviews, booking services, and notifications. Expansion into other African countries is planned within two to three years after success in the Nigerian market. The company is also exploring future revenue streams such as a subscription model, referral fees, and data analytics.

Management Comments

• The company has no sufficient revenue and has incurred losses since inception.
• Our Naploy App is your go-to source for the latest health news and updates.
• Symptom Diagnostics are an innovative addition to digital health. This tool does not provide medical advice.
• We are offering our services to the clients in Nigeria and then we are going to spread our services in other African countries.
• We are a development stage corporation with limited operations and no sufficient revenues from our business operations.
• Our auditors have issued a going concern opinion. This means that our auditors believe there is substantial doubt that we can continue as an on-going business for the next twelve months.
• We do not have any employees, only our officers and Directors.

Industry Context

StockSavvy.ai notes that Naploy Corp. is entering the highly competitive digital health market, which has seen increased demand due to the COVID-19 pandemic. While the company aims to differentiate itself with AI-driven diagnostics and a comprehensive health information platform, it faces significant challenges from established players and the inherent difficulties of scaling a startup in this sector.

Comparison to Industry Standards

• Competitors like Zocdoc, Healthgrades, and WebMD offer established platforms with significant user bases and revenue streams, setting a high bar for new entrants.
• The average user acquisition cost in the health app market can be substantial, posing a challenge for Naploy Corp. given its limited revenue and funding.
• Industry standards for AI diagnostic tools require rigorous validation and regulatory approval, which Naploy Corp. currently bypasses by stating its tool is for informational purposes only and not medical advice.

Corporate Governance

Legal Proceedings

• The company is not involved in any pending legal proceedings, nor is it aware of any pending or threatened litigation against it.

Related Party Transactions

• As of July 31, 2026, the amount due to Director Mr. Rafael Angel Ulloa Bonilla was $81,083, comprising $60,083 for operating expenses paid on behalf of the company and $21,000 for services provided by him.
• Frederick Sidney Reinhard Arnold was issued 2,000,000 shares of common stock for $200 to cover incorporation fees and business development.

Stakeholder Impact

• Shareholders: Potential for significant dilution if additional capital is raised through equity sales. The company's going concern status and lack of profitability pose risks to investment value.
• Creditors: The company's substantial liabilities and negative equity raise concerns about its ability to meet its obligations.
• Employees: Currently, there are no employees other than the two officers/directors, indicating minimal immediate impact on a broader workforce.

Next Steps

• Continue development and expansion of the Naploy App's functionality.
• Improve AI technology, add Map View, Reviews, Booking Services, and Notifications.
• Expand services to other African countries within two to three years.
• Explore future revenue streams including subscription models, referral fees, and data analytics.
• Hire freelance managers once the first client is secured.

Key Dates

Recommendation

The company is in a development stage with minimal revenue, significant losses, and a substantial accumulated deficit. The auditor's going concern opinion highlights severe financial instability, and material weaknesses in internal controls further increase risk. The lack of employees and clients, coupled with intense market competition, presents a very high risk profile for investors.

Keywords

health app, news blog, symptom checker, AI diagnosis, clinic search, healthcare advertising, digital health, Nigeria